BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8580085)

  • 1. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines.
    Peter ME; Dhein J; Ehret A; Hellbardt S; Walczak H; Moldenhauer G; Krammer PH
    Int Immunol; 1995 Nov; 7(11):1873-7. PubMed ID: 8580085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dormancy and cell signaling: anti-mu-induced apoptosis in human B-lymphoma cells is not caused by an APO-1-APO-1 ligand interaction.
    Racila E; Hsueh R; Marches R; Tucker TF; Krammer PH; Scheuermann RH; Uhr JW
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2165-8. PubMed ID: 8700902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95).
    Dhein J; Walczak H; Bäumler C; Debatin KM; Krammer PH
    Nature; 1995 Feb; 373(6513):438-41. PubMed ID: 7530335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation.
    Janssen O; Lengl-Janssen B; Oberg HH; Robertson MJ; Kabelitz D
    Immunol Lett; 1996 Jan; 49(1-2):63-9. PubMed ID: 8964611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
    Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
    Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
    Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
    Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis.
    Karas M; Zaks TZ; Yakar S; Dudley ME; LeRoith D
    Hum Immunol; 2001 Jan; 62(1):32-8. PubMed ID: 11165713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
    Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC
    J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.
    Sytwu HK; Liblau RS; McDevitt HO
    Immunity; 1996 Jul; 5(1):17-30. PubMed ID: 8758891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors.
    Salmon RA; Foltz IN; Young PR; Schrader JW
    J Immunol; 1997 Dec; 159(11):5309-17. PubMed ID: 9548470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
    J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
    McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
    Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis.
    Levy Y; Benlagha K; Buzyn A; Colombel M; Brouet JC; Lassoued K
    Clin Exp Immunol; 1997 Nov; 110(2):329-35. PubMed ID: 9367421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
    Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
    Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines.
    Fellenberg J; Mau H; Scheuerpflug C; Ewerbeck V; Debatin KM
    Int J Cancer; 1997 Jul; 72(3):536-42. PubMed ID: 9247301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.